On January 5, 2021 Oncternal Therapeutics (Nasdaq: ONCT), reported that James Breitmeyer, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat hosted by H.C. Wainwright on Monday, January 11, 2021 (Press release, Oncternal Therapeutics, JAN 5, 2021, View Source [SID1234573499]). The discussion may cover Oncternal’s recent progress, upcoming catalysts, and plans for 2021. Please see additional details below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright BioConnect 2021 Conference (Virtual)

Title: Oncternal Therapeutics (ONCT) Fireside Chat
Date: Monday, January 11th 2021
Time: On-demand starting at 6am EST
Presenter: James Breitmeyer, President & CEO

Webcasting Link:

Click Here
Replay Link:
A replay will be accessible on the Events & Presentations page of the Investors section on the Company’s website at View Source